-
More subject diversity is needed in clinical trials to reduce the risk of adverse outcomes, according to the keynote speaker at the Clinical Trials in Georgia conference.
-
Research institutions should make their complaint process as accessible as possible to researchers, participants, and others, an expert says.
-
The Presidential Commission for the Study of Bioethical Issues (PCSBI) has made these 12 recommendations for how to better develop public trust and protect privacy in the era of whole genome sequencing in research:
-
With the smartphone application market seemingly exploding with apps for just about anything, it's no surprise that clinical research is starting to get in on the action. Technology companies and academic institutions are working on research apps and other programs to assist with clinical trial data reporting.
-
Medical and electronic data advances in the 21st century have made it possible to determine the entire DNA sequence of any individual on the planet. The first question that many bioethicists ask is, "How do you protect individuals' privacy from the misuse or unauthorized use of this information?"
-
-
-
A memo to the Centers from Medicare & Medicaid Services (CMS) from two leading surgeons on the literal cutting edge of infection prevention in the OR: Hospitals and federal regulators should encourage the use of newer and safer types of surgery and more transparency with patients on procedure options and possible outcomes.
-
A study by the University of Michigan (U-M) Health System in Ann Arbor showed 1 in 84 highest-risk patients suffers a dangerous blood clot after surgery.
-
On the surface, evacuating a facility might seem like a simple and straightforward process, but have you ever thought through exactly how you would evacuate patients, some of whom might be in surgery, as well as staff and families? Although such a scenario might seem far-fetched, consider these three recent examples:
